BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ballarò R, Lopalco P, Audrito V, Beltrà M, Pin F, Angelini R, Costelli P, Corcelli A, Bonetto A, Szeto HH, O'Connell TM, Penna F. Targeting Mitochondria by SS-31 Ameliorates the Whole Body Energy Status in Cancer- and Chemotherapy-Induced Cachexia. Cancers (Basel) 2021;13:850. [PMID: 33670497 DOI: 10.3390/cancers13040850] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Argilés JM, López-Soriano FJ, Stemmler B, Busquets S. Cancer-associated cachexia - understanding the tumour macroenvironment and microenvironment to improve management. Nat Rev Clin Oncol 2023;20:250-64. [PMID: 36806788 DOI: 10.1038/s41571-023-00734-5] [Reference Citation Analysis]
2 Zinovkin RA, Lyamzaev KG, Chernyak BV. Current perspectives of mitochondria-targeted antioxidants in cancer prevention and treatment. Front Cell Dev Biol 2023;11. [DOI: 10.3389/fcell.2023.1048177] [Reference Citation Analysis]
3 Lambert CP. Recent Advances in Metabolomics and Therapeutics for Cancer Cachexia. JCT 2023;14:38-49. [DOI: 10.4236/jct.2023.141004] [Reference Citation Analysis]
4 Delfinis LJ, Bellissimo CA, Gandhi S, DiBenedetto SN, Garibotti MC, Thuhan AK, Tsitkanou S, Rosa-Caldwell ME, Rahman FA, Cheng AJ, Wiggs MP, Schlattner U, Quadrilatero J, Greene NP, Perry CG. Muscle weakness precedes atrophy during cancer cachexia and is linked to muscle-specific mitochondrial stress. JCI Insight 2022;7. [PMID: 36346680 DOI: 10.1172/jci.insight.155147] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hain BA, Waning DL. Bone-Muscle Crosstalk: Musculoskeletal Complications of Chemotherapy. Curr Osteoporos Rep 2022;20:433-41. [PMID: 36087213 DOI: 10.1007/s11914-022-00749-4] [Reference Citation Analysis]
6 Chen T, Koh K, Lin KM, Chou C. Mitochondrial Dysfunction as an Underlying Cause of Skeletal Muscle Disorders. IJMS 2022;23:12926. [DOI: 10.3390/ijms232112926] [Reference Citation Analysis]
7 Huot JR, Pin F, Chatterjee R, Bonetto A. PGC1α overexpression preserves muscle mass and function in cisplatin-induced cachexia. J Cachexia Sarcopenia Muscle 2022;13:2480-91. [PMID: 35903870 DOI: 10.1002/jcsm.13035] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Pauk M, Saito H, Hesse E, Taipaleenmäki H. Muscle and Bone Defects in Metastatic Disease. Curr Osteoporos Rep 2022. [PMID: 35994202 DOI: 10.1007/s11914-022-00741-y] [Reference Citation Analysis]
9 Halle JL, Counts BR, Zhang Q, Carson JA. Short duration treadmill exercise improves physical function and skeletal muscle mitochondria protein expression after recovery from FOLFOX chemotherapy in male mice. FASEB J 2022;36:e22437. [PMID: 35816153 DOI: 10.1096/fj.202200460R] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Hegde M, Daimary UD, Girisa S, Kumar A, Kunnumakkara AB. Tumor cell anabolism and host tissue catabolism-energetic inefficiency during cancer cachexia. Exp Biol Med (Maywood) 2022;:15353702221087962. [PMID: 35521962 DOI: 10.1177/15353702221087962] [Reference Citation Analysis]
11 Pin F, Huot JR, Bonetto A. The Mitochondria-Targeting Agent MitoQ Improves Muscle Atrophy, Weakness and Oxidative Metabolism in C26 Tumor-Bearing Mice. Front Cell Dev Biol 2022;10:861622. [DOI: 10.3389/fcell.2022.861622] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Cui P, Li X, Huang C, Li Q, Lin D. Metabolomics and its Applications in Cancer Cachexia. Front Mol Biosci 2022;9:789889. [DOI: 10.3389/fmolb.2022.789889] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
13 Chi M, Zhang H, Wang Y, Sun X, Yang Q, Guo C, Sakuma K. Silibinin Alleviates Muscle Atrophy Caused by Oxidative Stress Induced by Cisplatin through ERK/FoxO and JNK/FoxO Pathways. Oxidative Medicine and Cellular Longevity 2022;2022:1-22. [DOI: 10.1155/2022/5694223] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Lim S, Deaver JW, Rosa-Caldwell ME, Haynie WS, Morena da Silva F, Cabrera AR, Schrems ER, Saling LW, Jansen LT, Dunlap KR, Wiggs MP, Washington TA, Greene NP. Development of metabolic and contractile alterations in development of cancer cachexia in female tumor-bearing mice. J Appl Physiol (1985) 2022;132:58-72. [PMID: 34762526 DOI: 10.1152/japplphysiol.00660.2021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
15 Thibaut MM, Gillard J, Dolly A, Roumain M, Leclercq IA, Delzenne NM, Muccioli GG, Bindels LB. Bile Acid Dysregulation Is Intrinsically Related to Cachexia in Tumor-Bearing Mice. Cancers (Basel) 2021;13:6389. [PMID: 34945009 DOI: 10.3390/cancers13246389] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
16 Beltrà M, Pin F, Ballarò R, Costelli P, Penna F. Mitochondrial Dysfunction in Cancer Cachexia: Impact on Muscle Health and Regeneration. Cells 2021;10:3150. [PMID: 34831373 DOI: 10.3390/cells10113150] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
17 Delfinis LJ, Bellissimo CA, Gandhi S, Dibenedetto SN, Rosa-caldwell ME, Rahman FA, Wiggs MP, Schlattner U, Quadrilatero J, Greene NP, Perry CG. Muscle weakness precedes atrophy during cancer cachexia and is associated with muscle-specific mitochondrial stress.. [DOI: 10.1101/2021.09.15.460477] [Reference Citation Analysis]
18 Gunadi JW, Welliangan AS, Soetadji RS, Jasaputra DK, Lesmana R. The Role of Autophagy Modulated by Exercise in Cancer Cachexia. Life (Basel) 2021;11:781. [PMID: 34440525 DOI: 10.3390/life11080781] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Campelj DG, Goodman CA, Rybalka E. Chemotherapy-Induced Myopathy: The Dark Side of the Cachexia Sphere. Cancers (Basel) 2021;13:3615. [PMID: 34298829 DOI: 10.3390/cancers13143615] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
20 Li Y, Jin H, Chen Y, Huang T, Mi Y, Zou Z. Cancer cachexia: molecular mechanism and pharmacological management. Biochem J 2021;478:1663-88. [PMID: 33970218 DOI: 10.1042/BCJ20201009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]